Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lubetsky

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Haemostasis : JTH|December 23, 2004
Prophylaxis for travel-related thrombosis? NoA Lubetsky
Lancet (London, England)|June 17, 1999
Warfarin dose requirement and CYP2C9 polymorphismsH Halkin, A Lubetsky
The New England Journal of Medicine|April 20, 2001
Genetic susceptibility to venous thrombosisU Seligsohn, A Lubetsky
Journal of Endocrinological Investigation|June 9, 2007
Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axisY Toledano, A Lubetsky, I Shimon
Placenta|June 19, 2008
The role of placental breast cancer resistance protein in the efflux of glyburide across the human placentaE Pollex, A Lubetsky, G Koren
Clinical Pharmacology and Therapeutics|July 1, 1992
The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirementsA Lubetsky, U Seligsohn, D Ezra, et al.
Harefuah|August 1, 1992
[Atrial septal defects and embolic stroke in young adults]N Ash, A Lubetsky, D Ezra, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven)G Kenet, A Lubetsky, J Luboshitz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 18, 2015
Pharmacokinetic profile of Optivate® (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand diseaseR Shaikh-Zaidi, A Lubetsky, A Inbal, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2014
Oral surgery-associated postoperative bleeding in haemophilia patients - a tertiary centre's two decade experienceN Givol, A Hirschhorn, A Lubetsky, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Haemostasis : JTH|December 23, 2004
Prophylaxis for travel-related thrombosis? NoA Lubetsky
Lancet (London, England)|June 17, 1999
Warfarin dose requirement and CYP2C9 polymorphismsH Halkin, A Lubetsky
The New England Journal of Medicine|April 20, 2001
Genetic susceptibility to venous thrombosisU Seligsohn, A Lubetsky
Journal of Endocrinological Investigation|June 9, 2007
Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axisY Toledano, A Lubetsky, I Shimon
Placenta|June 19, 2008
The role of placental breast cancer resistance protein in the efflux of glyburide across the human placentaE Pollex, A Lubetsky, G Koren
Clinical Pharmacology and Therapeutics|July 1, 1992
The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirementsA Lubetsky, U Seligsohn, D Ezra, et al.
Harefuah|August 1, 1992
[Atrial septal defects and embolic stroke in young adults]N Ash, A Lubetsky, D Ezra, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven)G Kenet, A Lubetsky, J Luboshitz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 18, 2015
Pharmacokinetic profile of Optivate® (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand diseaseR Shaikh-Zaidi, A Lubetsky, A Inbal, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2014
Oral surgery-associated postoperative bleeding in haemophilia patients - a tertiary centre's two decade experienceN Givol, A Hirschhorn, A Lubetsky, et al.
Pageof 5